According to Nobili et al., in children with NAFLD, hepatic FXR and circulating FGF19 levels were lower than those in control subjects, decreasing FGFR4 signaling and promoting NAFLD [90]. Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.